Triamterene And Hydrochlorothiazide Capsule
Product Images NDC 33342-467

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 33342-467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

123 (Triametrin And Hctz Capsules 37 5 25 mg 100)

123 (Triametrin And Hctz Capsules 37 5 25 mg 100)
Each capsule of Maczops contains Triamterene (USP) 37.5mg and Hydrochlorothiazide (USP) 25mg. The capsules meet Drug Release Test 3 as published in the current USP monograph for Triamterene and Hydrochlorothiazide. The usual dosage is 1 or 2 capsules once daily. It is advised to protect the capsules from light and store them at 20°C to 25°C. Maczops is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. Each pack contains 100 capsules and is Code No.: HP/152/07.*
FDA Label Image

543 (Triametrin And Hctz Capsules 37 5 25 mg 1000)

543 (Triametrin And Hctz Capsules 37 5 25 mg 1000)
This text provides information on Triamterene and Hydrochlorothiazide Capsules. This medication includes 37.5 mg of Triamterene and 25 mg of Hydrochlorothiazide per capsule. The usual dosage is 1 or 2 capsules once daily, as indicated in the prescribing information. The capsules meet Drug Release Test 3 according to the USP monograph. It should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The manufacturer is Macleods Pharma USA, Inc. and these capsules are manufactured in India by Macleods Pharmaceuticals Ltd. It is advised to protect the medication from light and dispense it in a tight, light-resistant container. Safety closures should be used unless otherwise directed by a physician or requested by the purchaser.*
FDA Label Image

178 (Triamterene Hydrochlorothiazide Struct Hctz)

178 (Triamterene Hydrochlorothiazide Struct Hctz)
FDA Label Image

159 (Triamterene Hydrochlorothiazide Struct Triam)

159 (Triamterene Hydrochlorothiazide Struct Triam)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.